HEPION PHARMACEUTICALS, INC. Convertible Preferred Stock, Shares Issued upon Conversion
HEPION PHARMACEUTICALS, INC. (HEPA) had Convertible Preferred Stock, Shares Issued upon Conversion of 1.21 thousand shares as of 2019-06-30, per its 10-Q filed 2019-08-14.
Discontinued › Notes › Stockholders' Equity Note › Features of Convertible Preferred Stock
us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion · last filed 2019-08-14
- 2019-06-30: Convertible Preferred Stock, Shares Issued upon Conversion 1.21K shares.
- 2019-03-31: Convertible Preferred Stock, Shares Issued upon Conversion 29.68K shares.
- 2018-12-31: Convertible Preferred Stock, Shares Issued upon Conversion 81.58K shares; Convertible Preferred Stock, Shares Issued upon Conversion as first filed 5.71M shares.
- 2018-09-30: Convertible Preferred Stock, Shares Issued upon Conversion 43.32K shares; Convertible Preferred Stock, Shares Issued upon Conversion as first filed 2.80M shares.
| Period end | Convertible Preferred Stock, Shares Issued upon Conversion | Convertible Preferred Stock, Shares Issued upon Conversion as first filed |
|---|---|---|
| 2019-06-30 | 1.21K shares 10-Q · filed 2019-08-14 | |
| 2019-03-31 | 29.68K shares 10-Q · filed 2019-05-15 | |
| 2018-12-31 | 81.58K shares 10-Q · filed 2019-08-14 | 5.71M shares 10-K · filed 2019-03-14 |
| 2018-09-30 | 43.32K shares 10-Q · filed 2019-08-14 | 2.80M shares 10-Q · filed 2018-11-14 |
| 2016-09-30 | 138.00K shares 10-Q · filed 2018-11-14 | 1.10M shares 10-Q · filed 2017-11-14 |
| 2016-09-29 | 2.80M shares 10-Q · filed 2018-08-14 | 22.20M shares 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |